<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Haslbauer JD</submitter><funding>Fondation Botnar</funding><pubmed_abstract>Although initial immunophenotypical studies on peripheral blood and bronchoalveolar lavage samples have provided a glimpse into the immunopathology of COVID-19, analyses of pulmonary draining lymph nodes are currently scarce. 22 lethal COVID-19 cases and 28 controls were enrolled in this study. Pulmonary draining lymph nodes (mediastinal, tracheal, peribronchial) were collected at autopsy. Control lymph nodes were selected from a range of histomorphological sequelae [unremarkable histology, infectious mononucleosis, follicular hyperplasia, non-SARS related HLH, extrafollicular plasmablast activation, non-SARS related diffuse alveolar damage (DAD), pneumonia]. Samples were mounted on a tissue microarray and underwent immunohistochemical staining for a selection of immunological markers and </pubmed_abstract><journal>Frontiers in immunology</journal><pagination>763098</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8710573</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19.</pubmed_title><pmcid>PMC8710573</pmcid><pubmed_authors>Zinner C</pubmed_authors><pubmed_authors>Bassetti S</pubmed_authors><pubmed_authors>Stalder AK</pubmed_authors><pubmed_authors>Menter T</pubmed_authors><pubmed_authors>Matter MS</pubmed_authors><pubmed_authors>Mertz KD</pubmed_authors><pubmed_authors>Haslbauer JD</pubmed_authors><pubmed_authors>Schneeberger J</pubmed_authors><pubmed_authors>Went P</pubmed_authors><pubmed_authors>Tzankov A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19.</name><description>Although initial immunophenotypical studies on peripheral blood and bronchoalveolar lavage samples have provided a glimpse into the immunopathology of COVID-19, analyses of pulmonary draining lymph nodes are currently scarce. 22 lethal COVID-19 cases and 28 controls were enrolled in this study. Pulmonary draining lymph nodes (mediastinal, tracheal, peribronchial) were collected at autopsy. Control lymph nodes were selected from a range of histomorphological sequelae [unremarkable histology, infectious mononucleosis, follicular hyperplasia, non-SARS related HLH, extrafollicular plasmablast activation, non-SARS related diffuse alveolar damage (DAD), pneumonia]. Samples were mounted on a tissue microarray and underwent immunohistochemical staining for a selection of immunological markers and </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-07T23:30:56.413Z</modification><creation>2022-02-11T14:36:55.446Z</creation></dates><accession>S-EPMC8710573</accession><cross_references><pubmed>34966385</pubmed><doi>10.3389/fimmu.2021.763098</doi></cross_references></HashMap>